Article
Transcriptomically-inferred PI3K activity and stemness show a counterintuitive correlation with <i>PIK3CA</i> genotype in breast cancer
2020-07-09
Abstract excerpt
<h4>ABSTRACT</h4> A PI3Kα-selective inhibitor has recently been approved for use in breast tumours harbouring mutations in PIK3CA , the gene encoding PI3Kα. Preclinical studies have suggested that the PI3K/AKT/mTORC1 signalling pathway influences stemness, a dedifferentiation-related cellular phenotype associated with aggressive cancer. No direct evidence for such a correlation has been demonstrated to date in h...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 203cfcbf-cf16-5e4a-9563-996626299ef7
- DOI
- 10.1101/2020.07.09.195974
